Gene therapy for central diabetes insipidus: Effective antidiuresis by muscle-targeted gene transfer

Endocrinology

Volumn 145, Issue 1, 2004, Pages 261-268

  Yoshida, Masanori ^a   Iwasaki, Yasumasa ^a   Asai, Masato ^a   Nigawara, Takeshi ^a   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Electroporation; Furin; Gene therapy; Processing; Vasopressin

Indexed keywords

DESMOPRESSIN ACETATE; FURIN; MOZAVAPTAN; VASOPRESSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDIURESIS; ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; DRUG EFFECT; DRUG TARGETING; ELECTROPORATION; GENE EXPRESSION; GENE LOCATION; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; LONG TERM CARE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; RAT; SKELETAL MUSCLE; WILD TYPE;

ANIMALS; COS CELLS; DIABETES INSIPIDUS, NEUROGENIC; DIURESIS; FURIN; GENE THERAPY; LLC-PK1 CELLS; MALE; MUSCLE, SKELETAL; MYOBLASTS; NEUROSECRETORY SYSTEMS; RATS; RATS, BRATTLEBORO; SWINE; TRANSFECTION; VASOPRESSINS;

EID: 1042275335     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0366     Document Type: Article

References (50)

1. Robertson GL 1976 The regulation of vasopressin function in health and disease. Recent Prog Horm Res 33:333-385
2. Barr E, Leiden JM 1991 Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254:1507-1509
3. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM 1991 Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254:1509-1512
4. Al-Hendy A, Hortelano G, Tannenbaum GS, Chang PL 1995 Correction of the growth defect in dwarf mice with non-autologous microencapsulated myoblasts-an alternate approach to somatic gene therapy. Hum Gene Ther 6:165-175
5. Rivera VM, Ye X, Courage NL, Sachar J, Cerasoli F Jr, Wilson JM, Gilman M 1999 Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc Natl Acad Sci USA 96:8657-8662
6. Schmale H, Richter D 1984 Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature 308:705-709
7. Geddes BJ, Harding TC, Lightman SL, Uney JB 1997 Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nat Med 12:1402-1404
8. Valtin H 1967 Hereditary hypothalamic diabetes insipidus in rats (Brattleboro strain). A useful experimental model. Am J Med 42:814-827
9. Majzoub JA, Pappey A, Burg R, Habener JF 1984 Vasopressin gene is expressed at low levels in the hypothalamus of the Brattleboro rat. Proc Natl Acad Sci USA 17:5296-5299
10. Blotner H 1958 Primary or idiopathic diabetes insipidus : A system disease. Metabolism 7:191-200
11. Bergeron C, Kovacs K, Ezrin C, Mizzen C 1991 Hereditary diabetes insipidus: an immunohistochemical study of the hypothalamus and pituitary gland. Acta Neuropathol (Berl) 3:345-348
12. Ivell R, Richter D 1984 Structure and comparison of the oxytocin and vasopressin genes from rat. Proc Natl Acad Sci USA 81:2006-2010
13. Dong W, Seidel B, Marcinkiewicz M, Chretien M, Seidah NG, Day R 1997 Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids. J Neurosci 17:563-575
14. Coates LC, Birch NP 1998 Differential cleavage of provasopressin by the major molecular forms of SPC3. J Neurochem 70:1670-1678
15. Zhou A, Webb G, Zhu X, Steiner DF 1999 Proteolytic processing in the secretory pathway. J Biol Chem 274:20745-20748
16. Cwikel BJ, Habener JF 1987 Provasopressin-neurophysin II processing is cell-specific in heterologous cell lines expressing a metallothionein- vasopressin fusion gene. J Biol Chem 262:14235-14240
17. Nakayama K 1997 Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327:625-635
18. Aihara H, Miyazaki J 1998 Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867-870
19. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B, Scherman D 1999 High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 96:4262-4267
20. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P, Mathiesen I, Cortese R, Ciliberto G, Laufer R, La Monica N, Fattori E 1999 Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 96:6417-6422
21. Somiari S, Glasspool-Malone J, Drabick JJ, Gilbert RA, Heller R, Jaroszeski MJ, Malone RW 2000 Theory and in vivo application of electroporative gene delivery. Mol Ther 2:178-187
22. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL 1990 Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468
23. Tokui M, Takei I, Tashiro F, Shimada A, Kasuga A, Ishii M, Ishii T, Takatsu K, Saruta T, Miyazaki J 1997 Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5. Biochem Biophys Res Commun 233:527-531
24. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, Isner JM 1996 Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94:3281-3290.
25. Niwa H, Yamamura K, Miyazaki J 1991 Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199
26. Zhou A, Bloomquist BT, Mains RE 1993 The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 268:1763-1769
27. Iwasaki Y, Oiso Y, Saito H, Majzoub JA 1997 Positive and negative regulation of the rat vasopressin gene promoter. Endocrinology 138:5266-5274
28. Yamamura Y, Ogawa H, Yamashita H, Chihara T, Miyamoto H, Nakamura S, Onogawa T, Yamashita T, Hosokawa T, Mori T 1992 Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol 105:787-791
29. Fujisawa G, Ishikawa S, Tsuboi Y, Okada K, Saito T 1993 Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int 44:19-23
30. Nagasaki H, Yokoi H, Arima H, Hirabayashi Y, Ishizaki S, Tachikawa K, Murase T, Miura Y, Oiso Y 2002 Overexpression of vasopressin in the rat transgenic for the metallothionein-vasopressin fusion gene. J Endocrinol 173:35-44
31. Oiso Y, Iwasaki Y, Kondo K, Takatsuki K, Tomita A 1988 Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis. Neuroendocrinology 48:658-662
32. Ausiello DA, Hall DH, Dayer JM 1980 Modulation of cyclic AMP-dependent protein kinase by vasopressin and calcitonin in cultured porcine renal LLC-PK1 cells. Biochem J 186:773-780
33. Anderson WF 1998 Human gene therapy. Nature 392:25-30
34. Nishikawa M, Huang L 2001 Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12:861-870
35. Barzon L, Bonaguro R, Palu G, Boscaro M 2000 New perspectives for gene therapy in endocrinology. Eur J Endocrinol 143:447-466
36. Bloomquist BT, Eipper BA, Mains RE 1991 Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA. Mol Endocrinol 5:2014-2024
37. Davidson HW, Rhodes CJ, Hutton JC 1988 Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature 333:93-96
38. Rothenberg ME, Eilertson CD, Klein K, Zhou Y, Lindberg I, McDonald JK, Mackin RB, Noe BD 1995 Processing of mouse proglucagon by recombinant prohormone convertase 1 and immunopurified prohormone convertase 2 in vitro J Biol Chem 270:10136-10146
39. Yanagita M, Nakayama K, Takeuchi T 1992 Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7. FEBS Lett 311:55-59
40. Gros L, Riu E, Montoliu L, Ontiveros M, Lebrigand L, Bosch F 1999 Insulin production by engineered muscle cells. Hum Gene Ther 10:1207-1217
41. Lee HC, Kim SJ, Kim KS, Shin HC, Yoon JW. 2000 Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 408:483-488
42. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH 1982 Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841-845
43. Titomirov AV, Sukharev S, Kistanova E 1991 In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1088:131-134
44. Heller R, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J, Nicolau C 1996 In vivo gene electroinjection and expression in rat liver. FEBS Lett 89:225-228
45. Gage FH 1998 Cell therapy. Nature 392:18-24.
46. Chang PL 1997 Microcapsules as bio-organs for somatic gene therapy. Ann N Y Acad Sci 831:461-473
47. Campbell AI, Zhao Y, Sandhu R, Stewart DJ 2001 Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104:2242-2248
48. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub, MH 2001 Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104:1207-1212
49. Raymon HK, Thode S, Gage FH 1997 Application of ex vivo gene therapy in the treatment of Parkinson's disease. Exp Neurol 144:82-91
50. Chen BF, Chang WC, Chen ST, Chen DS, Hwang LH 1995 Long-term expression of the biologically active growth hormone in genetically modified fibroblasts after implantation into a hypophysectomized rat. Hum Gene Ther 6: 917-926